Pennsylvania Department of Health
KING OF PRUSSIA SKILLED NURSING AND REHABILITATION CENTER
Patient Care Inspection Results

Note: If you need to change the font size, click the "View" menu at the top of the page, place the mouse over the "Text Size" menu item, and select the desired font size.

Severity Designations

Click here for definitions Click here for definitions Click here for definitions Click here for definitions
Minimal Citation - No Harm Minimal Harm Actual Harm Serious Harm
KING OF PRUSSIA SKILLED NURSING AND REHABILITATION CENTER
Inspection Results For:

There are  210 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
KING OF PRUSSIA SKILLED NURSING AND REHABILITATION CENTER - Inspection Results Scope of Citation
Number of Residents Affected
By Deficient Practice
Initial comments:

Based on a Medicare/Medicaid, Recertification, State Licensure and Civil Rights Compliance survey as well as complaint investigation completed on August 14, 2026, it was determined that King of Prussia Skilled Nursing and Rehabilitation was not in compliance with the following requirements of 42 CFR 483, Subpart B, Requirements for Long Term Care and the 28 PA Code, Commonwealth of Pennsylvania Long Term Care Licensure Regulations as it relates to the Health portion of the survey process.\~




 Plan of Correction:


483.60(i)(1)(2) REQUIREMENT Food Procurement,Store/Prepare/Serve-Sanitary:This is a less serious (but not lowest level) deficiency but was found to be widespread throughout the facility and/or has the potential to affect a large portion or all the residents.  This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.60(i) Food safety requirements.
The facility must -

§483.60(i)(1) - Procure food from sources approved or considered satisfactory by federal, state or local authorities.
(i) This may include food items obtained directly from local producers, subject to applicable State and local laws or regulations.
(ii) This provision does not prohibit or prevent facilities from using produce grown in facility gardens, subject to compliance with applicable safe growing and food-handling practices.
(iii) This provision does not preclude residents from consuming foods not procured by the facility.

§483.60(i)(2) - Store, prepare, distribute and serve food in accordance with professional standards for food service safety.
Observations:

Based on observations and staff interviews, it was determined that the facility failed to ensure that food was stored and prepared in sanitary conditions in the main kitchen.

Findings:

An observation of the main kitchen conducted on August 11, 2026, at 6:59 a.m., in the presence of the food service director Employee E5, revealed the following: The steam table front bottom part had a dark brown/black sticky substance drips covering approximately two by five feet of the table; The wall behind the food preparation table had cracks with black substance scattered on the wall; and the wall by the kitchen entrance had a hole under ripped wallpaper with scattered black substance.

An observation of the main kitchen on August 13, 2026, at 9:52 a.m., in the presence of Employee E5, revealed that the above observations made on August 11, 2026, were still present.

An interview was conducted with Employee E5 on August 13, 2026, at 9:55 a.m. Employee E5 reported that the steam table was cleaned a week ago, but the bottom part was not cleaned. Employee E5 was unable to say how long the hole, cracks, and black substances on the walls were present.

The above was conveyed to the Nursing Home Administrator on August 13, 2026, at 3:00 p.m.

The facility failed to ensure that food was stored and prepared in sanitary conditions.

28 Pa. Code: 201.18(b)(3) Management

28 Pa. Code 211.6(d) Dietary services







 Plan of Correction - To be completed: 09/30/2026

Step 1
The steam table, including the front bottom portion thoroughly cleaned and sanitized to remove all dark brown/black sticky residue. The damaged walls, including the cracks and hole near the kitchen entrance, will be repaired, and all affected surfaces will be cleaned, sanitized accordingly .

Step 2
The Food Service Director/designee will conduct a comprehensive sanitation inspection of the kitchen, including food preparation areas, steam tables, walls, floors, equipment, and other food-contact and non-food-contact surfaces, to identify any additional areas requiring cleaning, repair, or sanitation. Any identified concerns will be corrected promptly

Step 3
Dietary Staff will be educated that all areas of kitchen equipment must be thoroughly cleaned and sanitized. Wall and floor surfaces must remain intact, free of holes and cracks, and maintained in a clean and sanitary condition. The Food Service Director/designee will be educated to maintain and reinforce a comprehensive cleaning schedule for the kitchen.

Step 4
The Food Service Director/designee will conduct sanitation audits weekly x 4, then monthly x 2 Findings will be reported to the QAPI Committee X 3 months for review.

483.10(g)(14)(i)-(iv)(15) REQUIREMENT Notify of Changes (Injury/Decline/Room, etc.):This is a less serious (but not lowest level) deficiency and affects more than a limited number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status. This deficiency was not found to be throughout this facility.
§483.10(g)(14) Notification of Changes.
(i) A facility must immediately inform the resident; consult with the resident's physician; and notify, consistent with his or her authority, the resident representative(s) when there is-
(A) An accident involving the resident which results in injury and has the potential for requiring physician intervention;
(B) A significant change in the resident's physical, mental, or psychosocial status (that is, a deterioration in health, mental, or psychosocial status in either life-threatening conditions or clinical complications);
(C) A need to alter treatment significantly (that is, a need to discontinue an existing form of treatment due to adverse consequences, or to commence a new form of treatment); or
(D) A decision to transfer or discharge the resident from the facility as specified in §483.15(c)(1)(ii).
(ii) When making notification under paragraph (g)(14)(i) of this section, the facility must ensure that all pertinent information specified in §483.15(c)(2) is available and provided upon request to the physician.
(iii) The facility must also promptly notify the resident and the resident representative, if any, when there is-
(A) A change in room or roommate assignment as specified in §483.10(e)(6); or
(B) A change in resident rights under Federal or State law or regulations as specified in paragraph (e)(10) of this section.
(iv) The facility must record and periodically update the address (mailing and email) and phone number of the resident
representative(s).

§483.10(g)(15)
Admission to a composite distinct part. A facility that is a composite distinct part (as defined in §483.5) must disclose in its admission agreement its physical configuration, including the various locations that comprise the composite distinct part, and must specify the policies that apply to room changes between its different locations under §483.15(c)(9).
Observations:

Based on a clinical records review and staff interviews, it was determined that the facility failed to notify the physician of a significant weight gain for three of eight residents reviewed (Resident 3, 4, and 103).

Findings:

A review of Resident 3's diagnosis list includes Congestive Heart Failure (CHF- when the heart cannot pump enough blood into the body to meet the metabolic needs) and chronic kidney disease (CKD-Gradual loss of kidney function, which can result in renal failure).

A review of Resident 3's physician's order dated April 28, 2025, revealed an order for daily weight, notify provider (physician) if gain greater than two pounds in one day, or five pounds in a week in the morning for HF (heart failure).

A review of Resident 3's weight and vitals revealed the resident's daily weight on July 26, 2026, was 173.2 pounds. On July 27, 2026, residents' weight was 177 pounds, a 3.8 pounds weight gain in a day. The weight remained at 177 pounds on July 28, 2026. There was no documentation that the physician was notified of the 3.8-pound weight gain on July 27, 2026.

A review of Resident 3's weight and vitals revealed the resident's daily weight on August 9, 2026, was 172.8 pounds. On August 10, 2026, residents' weight was 177.4 pounds, a 4.2 pounds weight gain in a day. The weight was 177 pounds on August 11, 2026. There was no documentation that the physician was notified of the 4.2-pound weight gain on August 10, 2026.

A review of Resident 4's diagnosis list includes Acute CHF and CKD.

A review of Resident 3's physician's order dated May 20, 2025, revealed an order for daily weights, call the physician if the gain is above three pounds in one day or five pounds in one week.

A review of Resident 4's weights and vitals revealed the resident's daily weight on July 10, 2026, was 180 pounds. There was no daily weight taken on July 11, 2026. On July 12, 2026, residents' daily weight was 187 pounds, a seven-pound weight gain in two days. There was no documentation of why daily weight was missing on July 11, 2026. There was no documentation that the physician was notified of the seven-pound weight gain identified on July 12, 2026.

An interview conducted with the Director of Nursing on August 13, 2026, at 10:00 a.m., confirmed that the facility did not follow the physician's order to call them if Resident 3 had a weight gain of two pounds in one day and if Resident 4 had a weight gain of three pounds in one day.

A review of Resident 103's diagnosis list includes a diagnosis of CHF.

A review of Resident 103's physician's order dated April 15, 2026, revealed an order to weigh the resident in the morning every Monday, Wednesday, and Friday for CHF.

A review of the physician's progress notes dated June 5, 2026, revealed the resident had bilateral lower extremity edema (swelling).

A review of Resident 103's weight and vitals revealed a weight of 305 pounds on June 12, 2026. On June 15, 2026, the resident's weight was 317 pounds, 12 pounds (3.93%) weight gain in two days. On June 17, 2026, the resident's weight was 336 pounds. A reweight was done on June 17, 2026, in the afternoon and revealed a weight of 337 pounds, a significant 20-pound (6.31%) weight gain in two days.

A review of the physician's progress notes dated June 26, 2026, at 8:36 p.m., revealed the resident had bilateral extremity edema. The note did not indicate that the physician was notified that the resident had a total of 32 pounds (10.49%) significant weight gain from June 12 until June 17, 2026 (five days).

A review of the dietitian's notes dated June 30, 2026, at 2:27 p.m., revealed: "Resident is triggering for significant weight gain x 1 month. Weight gain is undesirable". The same notes revealed, "Weight change is likely r/t (related to) weight fluctuations r/t fluid".

An interview with the dietitian, Employee E6, was conducted on August 13, 2026, at 1:00 p.m. Employee E6 reported that upon identifying a significant weight gain, the nursing staff should have completed a change in status assessment and the physician should have been notified.

An interview with the director of Nursing conducted on August 13, 2026, at 2:00 p.m., confirmed that the physician was not notified of Resident 103's significant weight gain identified on June 17, 2026.

The facility failed to ensure physicians were notified of significant weight gain of Resident 3, 4, and 103.

28 Pa. Code 211.5(f) Clinical Records

28 Pa. Code 211.12(d)(1)(5) Nursing Service






 Plan of Correction - To be completed: 09/30/2026

Step 1 The physician was notified of significant weight gains for Residents 3,4, and 103 in accordance with physician-ordered notification parameters.

Step 2: DON/Designee will complete an audit of residents with orders for routine/daily weights and physician-notification parameters to ensure significant weight changes meeting ordered parameters were identified, assessed, reported to the physician, and documented. Any identified concerns were corrected.

Step 3: NPE/DON/Designee re-educated licensed nursing staff regarding monitoring resident weights and following physician-ordered notification parameters. Education included timely assessment and notification of the physician and responsible party when weight gain/loss meets ordered parameters and documentation of notification, physician response, and interventions.

Step 4: DON/Designee will complete weekly audits X 4 then monthly X 2 of residents with routine/daily weight orders and notification parameters to ensure weights are reviewed, significant changes are identified, and physician/RP notification and follow-up are documented as ordered. Nursing will review weights in clinical and the Attending physician/designee will be informed of any weight gain/loss.DON/Designee will report findings of the audits to the QAPI Committee X 3 months.

483.45(d)(1)-(6) REQUIREMENT Drug Regimen is Free from Unnecessary Drugs:This is a less serious (but not lowest level) deficiency and affects more than a limited number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status. This deficiency was not found to be throughout this facility.
§483.45(d) Unnecessary Drugs-General.
Each resident's drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used-

§483.45(d)(1) In excessive dose (including duplicate drug therapy); or

§483.45(d)(2) For excessive duration; or

§483.45(d)(3) Without adequate monitoring; or

§483.45(d)(4) Without adequate indications for its use; or

§483.45(d)(5) In the presence of adverse consequences which indicate the dose should be reduced or discontinued; or

§483.45(d)(6) Any combinations of the reasons stated in paragraphs (d)(1) through (5) of this section.
Observations:

Based on a clinical records review and staff interviews, it was determined that the facility failed to ensure the resident was free from unnecessary pain medication for two of five residents reviewed (Residents 8 and 9).

Findings include:

Review of Resident 8's quarterly MDS (Minimum Data Set, a federally mandated assessment of a resident's functional capabilities and health needs), dated May 8, 2026, revealed that Resident 8 received scheduled pain medication and reported experiencing pain "occasionally." The assessment further indicated that pain "occasionally" interfered with sleep, participation in rehabilitation therapy sessions, and day-to-day activities.

Review of Resident 8's clinical record revealed diagnoses that included hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting the left non-dominant side (weakness or paralysis of the left side of the body following a stroke), depression (a persistent feeling of sadness or loss of interest), anxiety (excessive worry or feelings of apprehension), and lower back pain.

Review of Resident 8's August 2026 MAR (Medication Administration Record) revealed a physician's order for tramadol HCl 50 milligrams (mg), two tablets by mouth every eight hours as needed for moderate pain rated 4 through 6 on a numeric pain scale.

Further review of Resident 8's August 2026 MAR revealed that the resident's pain was to be assessed every eight hours utilizing a numeric pain scale (a scale used to rate pain from zero through 10, with zero indicating no pain and 10 indicating the most severe pain).

Review of the MAR revealed the Tramadol was administered following pain assessments that were documented as "NA" on the following instances:

August 1, 2026, at 5:50 p.m.
August 2, 2026, at 6:19 p.m.
August 3, 2026, at 8:06 a.m.
August 3, 2026, at 5:46 p.m.
August 4, 2026, at 6:10 p.m.
August 5, 2026, at 6:02 p.m.
August 6, 2026, at 6:25 p.m.
August 7, 2026, at 6:05 p.m.
August 8, 2026, at 8:53 a.m.
August 9, 2026, at 5:30 p.m.
August 10, 2026, at 10:06 a.m.
August 10, 2026, at 7:22 p.m.
August 11, 2026, at 5:46 p.m.
August 11, 2026, at 8:34 p.m.
August 12, 2026, at 6:53 p.m.
August 12, 2026, at 8:53 p.m.
August 13, 2026, at 10:03 a.m.

There was no documented pain rating to establish that Resident R8 was experiencing moderate pain rated 4 through 6 prior to administration of the as-needed tramadol on the identified occasions.

During an interview with the Director of Nursing on August 14, 2026, at approximately 12:30 p.m., the Director of Nursing confirmed that nursing staff were not documenting Resident 8's pain level prior to administering the resident's as-needed pain medication.

The facility failed to ensure that Resident 8's pain was assessed and documented prior to the administration of as-needed tramadol to determine that the resident's pain met the physician-ordered parameters of moderate pain rated 4 through 6.

This finding was shared with the Director of Nursing and Nursing Home Administrator on August 14, 2026, at approximately 1:50 p.m.

A review of Resident 9's diagnosis list includes Fibromyalgia (a long-term condition that involves widespread body pain) and Chronic pain syndrome (A condition where physical pain lasts longer than three to six months, continuing past the normal healing time).

A review of Resident 9's physician order dated November 4, 2025, revealed an order for Acetaminophen tablet (A medication used to treat mild pain) 325 mg, two tablets by mouth every six hours as needed for mild pain (Pain level 1-3). On May 1, 2026, an order for Oxycodone HCL (A medication used to treat moderate to severe pain) 5 mg: give one tablet by mouth every six hours as needed for moderate pain (Pain level 4-6).

A review of Resident 9 July and August 2026, Medication Administration Record (MAR) revealed that from July 6, 2026, until August 12, 2026, the resident was administered seven times with as-needed Oxycodone for a pain level of "0" on the following dates: July 6, 7, 16, 17, August 2, 3, and 12, 2026.

An interview with the Director of Nursing (DON) was conducted on August 13, 2026, at 10:00 a.m. The DON confirmed that Resident 9 should not have been administered as-needed Oxycodone for a pain level of "0".

The facility failed to ensure Resident 9 was free from unnecessary controlled pain medication.

28 Pa. Code 211.5(f) Clinical Records

28 Pa. Code 211.12(d)(1)(5) Nursing Services






 Plan of Correction - To be completed: 09/30/2026

Step 1: The prn pain parameters for resident 8 & 9 could not be retroactively corrected for the identified dates.

Step 2: DON/Designee will complete an audit of residents receiving PRN pain medications with parameters to ensure the medication orders contained appropriate pain-rating parameters and that pain assessments were documented prior to administration. The audit also ensured PRN pain medications were administered only when the resident's documented pain level met the physician-ordered parameters. Any identified concerns were corrected.

Step 3: NPE/DON/Designee re-educated licensed nursing staff regarding pain assessment and medication administration. Education included documenting the resident's pain level prior to administration of PRN pain medication, following the physician-ordered pain-scale parameters, documenting effectiveness/reassessment as required, and not administering PRN pain medication when the documented pain level does not meet the ordered indication. Nursing review of pain medications will ensure that the parameters are in place with admission/new medication orders.

Step 4: DON/Designee will audit residents receiving PRN pain medications with parameters for adherence to orders. weekly X 4 weeks, then monthly X 2 months to ensure pain levels are assessed and documented prior to medication administration and that medications are administered according to physician-ordered parameters. DON/Designee will report audit findings to the QAPI Committee X 3 months for review and further recommendations as indicated.

483.10(c)(1)(4)(5) REQUIREMENT Right to be Informed/Make Treatment Decisions:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.10(c) Planning and Implementing Care.
The resident has the right to be informed of, and participate in, his or her treatment, including:

§483.10(c)(1) The right to be fully informed in language that he or she can understand of his or her total health status, including but not limited to, his or her medical condition.

§483.10(c)(4) The right to be informed, in advance, of the care to be furnished and the type of care giver or professional that will furnish care.

§483.10(c)(5) The right to be informed in advance, by the physician or other practitioner or professional, of the risks and benefits of proposed care, of treatment and treatment alternatives or treatment options and to choose the alternative or option he or she prefers.
Observations:

Based on facility record reviews and staff interviews, it was determined that the facility failed to obtain informed consent for antipsychotic medication use from the legal representative of one of five resident's reviewed. (Resident 102)

Findings include:

Resident 102 has medical diagnoses that include Anoxic Brain Damage (injury to brain caused by lack of oxygen), Psychosis (experiencing hallucinations, delusions and disorganized thinking), Major Depressive Disorder (aserious mental health conditioncharacterized bypersistent feelings of sadness, hopelessness, or emptinessthat last for at leasttwo weeks and significantly interfere with daily life) and Paranoid Schizophrenia (a mental health condition where a person experiences fixed, false beliefs or delusions).

Resident 102's cognitive quarterly Minimum Data Set (MDS- clinical assessment of residents) dated May 14, 2026, documents the resident has a Brief Interview of Mental Status (BIMS- a standardized cognitive assessment used to evaluate memory, orientation and recall abilities), score of 15 indicating intact cognitive response with minimal or no impairment.

Review of Resident 102's miscellaneous records revealed a Court of Common Pleas of Delaware County, Pennsylvania, Orphans' Court Division, decree stating this 12th day of January 2026, it is ordered and decreed that Resident 102 is adjudicated an incapacitated person and is appointed a temporary, emergency Guardian of the Person and Estate, without prejudice and with powers and duties that include to determine any needs for and authorize/consent to the provision of medical treatment.

Review of Resident 102's physician orders revealed orders dated July 21, 2026, for Invega Sustenna Intramuscular Suspension (an extended-release intramuscular injectable suspension of paliperidone palmitate used for treating schizophrenia and schizoaffective disorder in adults) prefilled syringe 234 milligrams (mg)/1.5 milliliter (ml) inject 234 mg intramuscularly one time a day every 28 days for psychosis.

Review of Resident 102's paper chart revealed an informed consent form signed by Resident 102 on April 10, 2026, documenting the resident's consent and understanding of the risks and benefits of antipsychotic medication use.

During interview conducted with Social Service Director Employee E4 on August 14, 2026, at 9:25 a.m. Employee E4 confirmed Resident 102 was adjudicated and incapacitated person and was appointed a Guardian of Person and Estate by an Orphans' Court judge in January 2026, who is responsible for making

PA Code 201.29 (a)(c) Resident Rights

28 Pa. Code 211.10(c) Resident care policies








 Plan of Correction - To be completed: 09/30/2026

Step 1
R102 guardian was emailed for consent for use of antipsychotic medication
Step 2
DON/Designee will complete an audit of residents receiving antipsychotic medications to identify residents with guardians/legal representatives and ensure informed consent was obtained from the appropriate legal decision-maker and was present in the medical record. Any identified concerns were corrected.
Step 3
NPE/DON/Designee re-educated licensed nursing staff and Social Services regarding informed consent for psychotropic/antipsychotic medications, including verification of guardianship/legal decision-making authority prior to obtaining consent and ensuring the appropriate representative signs the consent when applicable.
step 4
DON/Designee will complete weekly audits X 4 then monthly X 2 of residents receiving antipsychotic medications to ensure informed consent is completed by the appropriate resident or legal representative and documentation is maintained in the medical record.DON/Designee will report findings of the audits to the QAPI Committee X 3 months.

483.10(c)(6)(8)(g)(12)(i)-(v) REQUIREMENT Request/Refuse/Dscntnue Trmnt;Formlte Adv Dir:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.10(c)(6) The right to request, refuse, and/or discontinue treatment, to participate in or refuse to participate in experimental research, and to formulate an advance directive.

§483.10(c)(8) Nothing in this paragraph should be construed as the right of the resident to receive the provision of medical treatment or medical services deemed medically unnecessary or inappropriate.

§483.10(g)(12) The facility must comply with the requirements specified in 42 CFR part 489, subpart I (Advance Directives).
(i) These requirements include provisions to inform and provide written information to all adult residents concerning the right to accept or refuse medical or surgical treatment and, at the resident's option, formulate an advance directive.
(ii) This includes a written description of the facility's policies to implement advance directives and applicable State law.
(iii) Facilities are permitted to contract with other entities to furnish this information but are still legally responsible for ensuring that the requirements of this section are met.
(iv) If an adult individual is incapacitated at the time of admission and is unable to receive information or articulate whether or not he or she has executed an advance directive, the facility may give advance directive information to the individual's resident representative in accordance with State law.
(v) The facility is not relieved of its obligation to provide this information to the individual once he or she is able to receive such information. Follow-up procedures must be in place to provide the information to the individual directly at the appropriate time.
Observations:

Based on clinical record review and staff interviews, it was determined that the facility failed to ensure that residents were provided the opportunity to formulate an advance directive and failed to provide evidence that the resident and/or resident representative was provided information or assistance, as needed, regarding the formulation of an advance directive for one of 32 residents reviewed. (Resident 49)

Findings include:

Resident 49 was admitted to the facility on July 3, 2026, with diagnoses that included muscle wasting and atrophy, not elsewhere classified, multiple sites; end stage renal disease (a condition in which the kidneys no longer function well enough to meet the body's needs); and dementia (a group of symptoms affecting memory, thinking, and social abilities).

Clinical record review for Resident R49 revealed an active physician's order dated July 3, 2026, indicating the resident was a DNR (Do Not Resuscitate, an order indicating that cardiopulmonary resuscitation is not to be initiated if the resident's heart stops beating or the resident stops breathing).

Review of the clinical record revealed no documented evidence that Resident R49 and/or the resident's representative was provided information regarding advance directives, offered the opportunity to formulate an advance directive, or provided assistance in formulating an advance directive, if needed.

Review of an Admission History and Physical Encounter document dated July 3, 2026, indicated, "Advanced Directives were discussed: The patient is a DNR." However, there was no additional documentation indicating that the resident was informed of the resident's right to formulate an advance directive or was offered assistance in developing an advance directive.

Additional information and documentation regarding advance directives for Resident R49 was requested during an interview with the Nursing Home Administrator and Director of Nursing on August 13, 2026, at 1:10 PM, and again on August 14, 2026, at 12:15 PM. No additional documentation was provided.

The facility failed to implement a process to ensure that Resident R49 was informed of the right to formulate an advance directive and was provided the opportunity and assistance, if needed, to develop an advance directive.

28 Pa. Code 201.29(a) Resident rights

28 Pa. Code 211.12(d)(1)(3)(5) Nursing services







 Plan of Correction - To be completed: 09/30/2026

Step1: Resident 49 and resident representative were provided information regarding advance directives, informed of the right to formulate an advance directive.

Step 2: Social Services Director/Designee will complete an audit of current residents to ensure documentation was present showing that the resident and/or resident representative was provided information regarding advance directives, informed of the right to formulate an advance directive, and offered assistance with completion when needed. Any identified concerns were corrected.

Step 3: NPE/Designee re-educated social services staff regarding advance directive requirements. Education included that documentation of DNR or Full Code status alone does not demonstrate that advance directive rights were provided. Staff were educated to document that the resident and/or representative received information regarding advance directives, was informed of the right to formulate one, and was offered assistance when applicable.

Step 4: Social Services Director/ Designee will complete weekly audits X 4 then monthly X 2 of newly admitted residents to ensure advance directive information, opportunity to formulate an advance directive, offer of assistance, and appropriate documentation are completed. Social Services Director/Designee will report findings of the audits to the QAPI Committee X 3 months.

483.15(c)(2)(iii)(3)-(6)(8)(d)(1)(2); 483.21(c)(2) REQUIREMENT Discharge Process:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.15(c)(2) Documentation.
When the facility transfers or discharges a resident under any of the circumstances specified in paragraphs (c)(1)(i)(A) through (F) of this section, the facility must ensure that the transfer or discharge is documented in the resident's medical record and appropriate information is communicated to the receiving health care institution or provider.
(iii) Information provided to the receiving provider must include a minimum of the following:
(A) Contact information of the practitioner responsible for the care of the resident.
(B) Resident representative information including contact information
(C) Advance Directive information
(D) All special instructions or precautions for ongoing care, as appropriate.
(E) Comprehensive care plan goals;
(F) All other necessary information, including a copy of the resident's discharge summary, consistent with §483.21(c)(2) as applicable, and any other documentation, as applicable, to ensure a safe and effective transition of care.

§483.15(c)(3) Notice before transfer.
Before a facility transfers or discharges a resident, the facility must-
(i) Notify the resident and the resident's representative(s) of the transfer or discharge and the reasons for the move in writing and in a language and manner they understand. The facility must send a copy of the notice to a representative of the Office of the State Long-Term Care Ombudsman.
(ii) Record the reasons for the transfer or discharge in the resident's medical record in accordance with paragraph (c)(2) of this section; and
(iii) Include in the notice the items described in paragraph (c)(5) of this section.

§483.15(c)(4) Timing of the notice.
(i) Except as specified in paragraphs (c)(4)(ii) and (c)(8) of this section, the notice of transfer or discharge required under this section must be made by the facility at least 30 days before the resident is transferred or discharged.
(ii) Notice must be made as soon as practicable before transfer or discharge when-
(A) The safety of individuals in the facility would be endangered under paragraph (c)(1)(i)(C) of this section;
(B) The health of individuals in the facility would be endangered, under paragraph (c)(1)(i)(D) of this section;
(C) The resident's health improves sufficiently to allow a more immediate transfer or discharge, under paragraph (c)(1)(i)(B) of this section;
(D) An immediate transfer or discharge is required by the resident's urgent medical needs, under paragraph (c)(1)(i)(A) of this section; or
(E) A resident has not resided in the facility for 30 days.

§483.15(c)(5) Contents of the notice. The written notice specified in paragraph (c)(3) of this section must include the following:

(i) The reason for transfer or discharge;
(ii) The effective date of transfer or discharge;
(iii) The location to which the resident is transferred or discharged;
(iv) A statement of the resident's appeal rights, including the name, address (mailing and email), and telephone number of the entity which receives such requests; and information on how to obtain an appeal form and assistance in completing the form and submitting the appeal hearing request;
(v) The name, address (mailing and email) and telephone number of the Office of the State Long-Term Care Ombudsman;
(vi) For nursing facility residents with intellectual and developmental disabilities or related disabilities, the mailing and email address and telephone number of the agency responsible for the protection and advocacy of individuals with developmental disabilities established under Part C of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (Pub. L. 106-402, codified at 42 U.S.C. 15001 et seq.); and
(vii) For nursing facility residents with a mental disorder or related disabilities, the mailing and email address and telephone number of the agency responsible for the protection and advocacy of individuals with a mental disorder established under the Protection and Advocacy for Mentally Ill Individuals Act.

§483.15(c)(6) Changes to the notice.
If the information in the notice changes prior to effecting the transfer or discharge, the facility must update the recipients of the notice as soon as practicable once the updated information becomes available.

§483.15(c)(8) Notice in advance of facility closure
In the case of facility closure, the individual who is the administrator of the facility must provide written notification prior to the impending closure to the State Survey Agency, the Office of the State Long-Term Care Ombudsman, residents of the facility, and the resident representatives, as well as the plan for the transfer and adequate relocation of the residents, as required at § 483.70(l).

§483.15(d) Notice of bed-hold policy and return-

§483.15(d)(1) Notice before transfer. Before a nursing facility transfers a resident to a hospital or the resident goes on therapeutic leave, the nursing facility must provide written information to the resident or resident representative that specifies-
(i) The duration of the state bed-hold policy, if any, during which the resident is permitted to return and resume residence in the nursing facility;
(ii) The reserve bed payment policy in the state plan, under § 447.40 of this chapter, if any;
(iii) The nursing facility's policies regarding bed-hold periods, which must be consistent with paragraph (e)(1 ) of this section, permitting a resident to return; and
(iv) The information specified in paragraph (e)(1) of this section.

§483.15(d)(2) Bed-hold notice upon transfer. At the time of transfer of a resident for hospitalization or therapeutic leave, a nursing facility must provide to the resident and the resident representative written notice which specifies the duration of the bed-hold policy described in paragraph (d)(1) of this section.

§483.21(c)(2) Discharge Summary
When the facility anticipates discharge, a resident must have a discharge summary that includes, but is not limited to, the following:
(i) A recapitulation of the resident's stay that includes, but is not limited to, diagnoses, course of illness/treatment or therapy, and pertinent lab, radiology, and consultation results.
(ii) A final summary of the resident's status to include items in paragraph (b)(1) of §483.20, at the time of the discharge that is available for release to authorized persons and agencies, with the consent of the resident or resident's representative.
(iii) Reconciliation of all pre-discharge medications with the resident's post-discharge medications (both prescribed and over-the-counter).
Observations:

Based on clinical record review and staff interview, it was determined that the facility failed to notify the Office of the State Long-Term Care Ombudsman of a transfer to the hospital for three of 27 residents reviewed (Resident 2, 12, and Resident 70).

Findings Include:

Review of Resident 2's clinical record revealed Resident 2 was transferred to the hospital on April 18, 2026, after the resident was found on the floor.

Resident 2 was admitted into the hospital on April 18, 2026, with a diagnosis of hypoglycemia.

Further review of Resident 2's clinical record revealed Resident 2 was readmitted to the facility on April 22, 2026.

Review of Resident 2's clinical record and facility documentation failed to reveal evidence that the State Ombudsman's office was notified of Resident 2's transfer and admission to the hospital.

Review of Resident 12's clinical record revealed Resident 12 was transferred to the hospital on April 13, 2026, after resident indicated suicidal ideations.

Resident 12 was admitted into the hospital on April 13, 2026, with a suicidal ideations and hyponatremia.

Further review of Resident 12's clinical record revealed Resident 12 was readmitted to the facility on April 17, 2026.

Review of Resident 12's clinical record and facility documentation failed to reveal evidence that the State Ombudsman's office was notified of Resident 12's transfer and admission to the hospital.

Review of Resident 70's clinical record revealed Resident 70 was transferred to the hospital on May 3, 2026, at the resident's request due to a fall.

Resident 70 was admitted into the hospital on May 3, 2026, with a diagnosis of pneumonia and hypoxic respiratory failure.

Further review of Resident 70's clinical record revealed Resident 70 was readmitted to the facility on May 12, 2026.

Review of Resident 70's clinical record revealed Resident 70 was transferred to the hospital on June 7, 2026, due to diarrhea and blood in stool.

Further review of Resident 70's clinical record revealed Resident 70 returned to the facility on June 9, 2026.

Review of Resident 70's clinical record and facility documentation failed to reveal evidence that the State Ombudsman's office was notified of Resident 1's transfer and admission to the hospital.

These findings were shared with the NHA (Nursing Home Administrator) and DON (Director of Nursing) on August 14, 2026, at approximately 1:15 p.m.

28 Pa. Code 201.18(a)(b)(1)(3) Management







 Plan of Correction - To be completed: 09/30/2026

Step 1: The Ombudsman was notified of hospital transfers/discharges for residents 2, 12, and 70, of the stated dates retroactively.

Step 2: An audit will be completed in the last 30 days to ensure the ombudsman was notified of discharged residents in the period reviewed.


Step 3: NPE/designee will re-educate Social Services and Admissions on the importance of issuing a written notice to the office of the State Long Term Care Ombudsman regarding any resident's hospitalization.

Step 4: Social Services to conduct weekly audits x12 weeks to verify all residents transfer to the hospital are reported to the office of the State Long Term Care Ombudsman. Social Services or designee will review outcome audits at QAPI committee x3 months

483.45(c)(1)(2)(4)(5) REQUIREMENT Drug Regimen Review, Report Irregular, Act On:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45(c) Drug Regimen Review.
§483.45(c)(1) The drug regimen of each resident must be reviewed at least once a month by a licensed pharmacist.

§483.45(c)(2) This review must include a review of the resident's medical chart.

§483.45(c)(4) The pharmacist must report any irregularities to the attending physician and the facility's medical director and director of nursing, and these reports must be acted upon.
(i) Irregularities include, but are not limited to, any drug that meets the criteria set forth in paragraph (d) of this section for an unnecessary drug.
(ii) Any irregularities noted by the pharmacist during this review must be documented on a separate, written report that is sent to the attending physician and the facility's medical director and director of nursing and lists, at a minimum, the resident's name, the relevant drug, and the irregularity the pharmacist identified.
(iii) The attending physician must document in the resident's medical record that the identified irregularity has been reviewed and what, if any, action has been taken to address it. If there is to be no change in the medication, the attending physician should document his or her rationale in the resident's medical record.

§483.45(c)(5) The facility must develop and maintain policies and procedures for the monthly drug regimen review that include, but are not limited to, time frames for the different steps in the process and steps the pharmacist must take when he or she identifies an irregularity that requires urgent action to protect the resident.
Observations:

Based upon clinical record review and interviews, it was determined that the facility failed to ensure that medication irregularities were appropriately acted upon by a physician for two of five residents reviewed (Resident 53, and Resident 108).

Findings include:

Review of Resident 53's monthly Pharmacist Medication Regime Reviews (MRR) revealed a MD (physician)Recommendation (title of the form used for pharmacy reviews) dated March 3, 2026, recommending evaluation of the continued need for Hydrocortisone cream ( a medicated cream used to relieve itching, redness, swelling, and inflammation of the skin)apply twice daily for rash and Clindamycin (antibiotic used to treat a variety of bacterial infections) apply twice daily for rash, please evaluate if resident's condition has improved/stabilized or underlying causes of symptoms have resolved and discontinuation is possible or that the signs and symptoms are persistent or clinically significant to warrant continued use. The physician agreed with and signed the recommendation. No date of physician signature was noted.

Review of Resident 53's August 2026, medication administration report revealed and order dated April 29, 2026, for Clindamycin Phos once daily external Gel 1%, apply to chest, back, arms, and legs topically every dayshift for rash was being administered.

Review of Resident 53's August 2026, medication administration report revealed an order dated April 29, 2026, for Hydrocortisone external cream2.5%, apply to chest, back, arms, and legs topically every day and evening shift was being administered.

No documentation of the pharmacy recommendations being followed was observed in the resident's records.

Review of Resident 108's monthly MRR revealed a MD Recommendation dated September 11, 2025, noting the resident received two Nonsteroidal Anti-Inflammatory Drugs (NSAIDS-medications that reduce pain, inflammation, and fever), Diclofenac gel (used to relieve pain, reduce inflammation, and lower fever 2 grams twice daily to neck, and Meloxicam (used primarily to relieve pain, inflammation, swelling, and stiffness) 15mg once daily, which pharmacist notes as being considered duplication of therapy. Per the pharmacist combination usage with oral NSAIDS is not recommended due to increased risk of adverse reactions including rectal hemorrhage and more frequent abnormal labs, do not use concomitantly unless benefit outweighs risk and monitor patient with periodic laboratory evaluations. Please consider discontinuing one of these NSAID orders.

The physician checked "disagree" on the MRR form and signed the form yet provided no rationale for the disagreement. The form was not dated by the physician.

Review of Resident 108's physician orders revealed an order dated January 30, 2026, for Meloxicam tablet 7.5 mg give one tablet by mouth one time a day for right knee pain.

Review of Resident 108's physician orders revealed an order dated January 15, 2026, for Voltaren Gel 1% (Diclofenac Sodium), apply to right knee topically four times a day for knee pain 2-gram dose.

Resident 108 continues to receive combination usage of NSAIDS despite pharmacy recommendation and physician's agreement to discontinue.

Interview conducted with the Nursing Home Administrator (NHA) and the Director of Nursing (DON) on August 13, 2026, at 11:22 a.m., when the above information was presented, the NHA and DON stated they would follow-up and look into the matter.

28 Pa. Code 211.10(c) Resident care policies

Pa Code 211.12 (c) Nursing Services

28 Pa. Code 211.12(d)(1)(5) Nursing services







 Plan of Correction - To be completed: 09/30/2026

Step 1: The pharmacy recommendations for residents 53 and 108. Physician responses could not be retroactively corrected.

Step 2: DON/Designee will complete an audit of current pharmacy medication regimen review recommendations of the preceding month to ensure each recommendation had been reviewed and acted upon by the physician, including appropriate signature/date, implementation of accepted recommendations, or documented clinical rationale when a recommendation was declined. Any identified refusal to recommendation has a reason.

Step 3: DON/NPE/Designee re-educated licensed nursing staff and applicable providers regarding the pharmacy medication regimen review process. Education included ensuring pharmacy recommendations are promptly forwarded to the physician, physician responses are dated and documented, accepted recommendations are implemented, and a clinical rationale is documented when the physician declines a pharmacist recommendation when required.

Step 4: DON/Designee will audit pharmacy recommendations weekly X 4 weeks, then monthly X 2 months to ensure recommendations are reviewed, appropriately acted upon, physician responses/rationales are documented, and resulting orders are implemented. DON/Designee will report audit findings to the QAPI Committee X 3 months for review and additional recommendations as indicated.

483.80(a)(1)(2)(4)(e)(f) REQUIREMENT Infection Prevention & Control:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.80 Infection Control
The facility must establish and maintain an infection prevention and control program designed to provide a safe, sanitary and comfortable environment and to help prevent the development and transmission of communicable diseases and infections.

§483.80(a) Infection prevention and control program.
The facility must establish an infection prevention and control program (IPCP) that must include, at a minimum, the following elements:

§483.80(a)(1) A system for preventing, identifying, reporting, investigating, and controlling infections and communicable diseases for all residents, staff, volunteers, visitors, and other individuals providing services under a contractual arrangement based upon the facility assessment conducted according to §483.71 and following accepted national standards;

§483.80(a)(2) Written standards, policies, and procedures for the program, which must include, but are not limited to:
(i) A system of surveillance designed to identify possible communicable diseases or
infections before they can spread to other persons in the facility;
(ii) When and to whom possible incidents of communicable disease or infections should be reported;
(iii) Standard and transmission-based precautions to be followed to prevent spread of infections;
(iv)When and how isolation should be used for a resident; including but not limited to:
(A) The type and duration of the isolation, depending upon the infectious agent or organism involved, and
(B) A requirement that the isolation should be the least restrictive possible for the resident under the circumstances.
(v) The circumstances under which the facility must prohibit employees with a communicable disease or infected skin lesions from direct contact with residents or their food, if direct contact will transmit the disease; and
(vi)The hand hygiene procedures to be followed by staff involved in direct resident contact.

§483.80(a)(4) A system for recording incidents identified under the facility's IPCP and the corrective actions taken by the facility.

§483.80(e) Linens.
Personnel must handle, store, process, and transport linens so as to prevent the spread of infection.

§483.80(f) Annual review.
The facility will conduct an annual review of its IPCP and update their program, as necessary.
Observations:

Based on observations and staff interviews, it was determined that the facility failed to provide appropriate notification of transmission-based precautions and display of personal protective devices for 1 of 27 residents reviewed. (Resident 79)

Findings include:

Resident 79 has medical diagnoses that include Hemiplegia (paralysis on one side), Hemiparesis (muscle weakness on one side) following Cerebral Infarction, Parkinsonism and the need for assistance with personal care.

Review of Resident 79's physician orders revealed an order dated July 30, 2026, to cleanse right buttock sacrum (triangular bone in the lower back) wound with wound cleaner (a substance or solution used toclean and disinfect a wound), honey gel (asemi-solid or liquid honey-based product that can be used to treat wounds), and silicone foam dressing (an advanced wound care product that combines thegentle, skin-friendly properties of siliconewith thehigh absorbency of foam) daily every dayshift for wound care and as needed for soilage/dressing dislodgement.

Resident 79 has a care plan focus initiated December 4, 2025, revised on July 23, 2026, for actual skin breakdown related to decreased activity, impaired sensation, incontinence, limited mobility, moisture/excessive perspiration, poor safety awareness, and pressure wound on right buttock.

Observations made on August 11, 2026, at 6:40 a.m., revealed no infection prevention Enhanced Barrier Precautions (EBP) signs or Personal Protection Equipment (PPE- gowns and gloves) for Resident 79's room.

Observations made on August 12, 20206, at 9:06 a.m., revealed wound care staff preparing for Resident 79's wound care treatment, no EBP signs or PPE was observed for Resident 79's room.

During interview conducted on August 12, 2026, at 9:10 a.m., Licensed Nurse Employee E7 confirmed Resident 79 had a stage 3 sacrum pressure ulcer and confirmed there was no EBP or PPE for the resident's room.

Further review of Resident 79's physician orders revealed an order dated August 13, 2026, for Infection precautions- enhanced barrier (wounds).

Interview conducted with the Nursing Home Administrator (NHA) and the Director of Nursing (DON) on August 13, 2026, at 11:22 a.m., when the above information was presented, the DON confirmed a resident with a stage 3 pressure ulcer should have EBP and PPE in place and stated she would investigate the matter.

28 Pa. Code 201.18(b)(1) Management

28 Pa. Code 211.5(f) Clinical records

28 Pa. Code 211.12(d)(1)(3)(5) Nursing services







 Plan of Correction - To be completed: 09/30/2026

1.Enhanced Barrier Precautions signage was posted and supplies were made available for R79 and orders were updated.

2. Infection Preventionist/DON/Designee will complete an audit of residents with wounds, indwelling medical devices, or other indications requiring Enhanced Barrier Precautions to ensure appropriate EBP signage was posted and the required PPE was readily available at the point of care. Any identified concerns were immediately corrected.

3. Infection Preventionist/NPE/DON/Designee re-educated nursing staff regarding Enhanced Barrier Precautions, including identification of residents requiring EBP, appropriate signage, availability and use of gowns and gloves during high-contact resident care activities, wound care, and maintaining PPE supplies at the point of care. Residents with infections will be reviewed in clinical meetings to ensure PPE requirements are discussed and in place per policy.

4. Infection Preventionist/DON/Designee will audit EBP compliance weekly X 4 weeks, then monthly X 2 months to ensure residents requiring Enhanced Barrier Precautions have appropriate signage posted and required PPE is available and utilized appropriately.
Infection Preventionist/DON/Designee will report audit findings to the QAPI Committee X 3 months for review and further recommendations as indicated.


Back to County Map


  
Home : Press Releases : Administration
Health Planning and Assessment : Office of the Secretary
Health Promotion and Disease Prevention : Quality Assurance



Copyright © 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement

Visit the PA Power Port